iTeos Therapeutics to Participate in Upcoming U.S. Conferences in September
August 29, 2018 07:00 ET
|
iTeos Therapeutics SA
iTeos Therapeutics to Participate in Upcoming U.S. Conferences in September Gosselies, Belgium – August 29, 2018 – iTeos Therapeutics SA, a biotechnology company developing novel cancer...
iTeos Therapeutics Appoints Scott Chappel as Chief Scientific Officer
July 03, 2018 07:00 ET
|
iTeos Therapeutics SA
iTeos Therapeutics Appoints Scott Chappel as Chief Scientific Officer Gosselies, Belgium – July 3, 2018 – iTeos Therapeutics SA, a biotechnology company developing novel cancer immunotherapies, today...
iTeos Therapeutics Appoints Scott Chappel as Chief Scientific Officer
July 03, 2018 01:00 ET
|
iTeos Therapeutics SA
iTeos Therapeutics Appoints Scott Chappel as Chief Scientific Officer Gosselies, Belgium – July 3, 2018 – iTeos Therapeutics SA, a biotechnology company developing novel cancer immunotherapies, today...
iTeos Therapeutics Expands Board of Directors with the Appointment of David Hallal as Chairman and Tim Van Hauwermeiren as an Independent Director
June 27, 2018 06:00 ET
|
iTeos Therapeutics SA
iTeos Therapeutics Expands Board of Directors with the Appointment of David Hallal as Chairman and Tim Van Hauwermeiren as an Independent Director Two new appointments follow oversubscribed $75...
iTeos Therapeutics Expands Board of Directors with the Appointment of David Hallal as Chairman and Tim Van Hauwermeiren as an Independent Director
June 27, 2018 01:00 ET
|
iTeos Therapeutics SA
iTeos Therapeutics Expands Board of Directors with the Appointment of David Hallal as Chairman and Tim Van Hauwermeiren as an Independent Director Two new appointments follow oversubscribed $75...
iTeos Therapeutics Completes $75 Million Series B Financing
June 20, 2018 07:00 ET
|
iTeos Therapeutics SA
iTeos Therapeutics Completes $75 Million Series B Financing Oversubscribed financing round led by new U.S. investor MPM Capital Proceeds to support accelerated development of innovative...
iTeos Therapeutics Completes $75 Million Series B Financing
June 20, 2018 01:00 ET
|
iTeos Therapeutics SA
iTeos Therapeutics Completes $75 Million Series B Financing Oversubscribed financing round led by new U.S. investor MPM Capital Proceeds to support accelerated development of innovative...